DMPK & Translational PK Consulting

Turning Preclinical Data into clear, Development focused Decisions

For pharma, biotech and CRO teams who need PK/TK analysis, translational insight, and reports they can act on.

10+ years pharmaceutical experience · Phoenix WinNonlin & R · Confidential data exchange under signed MOU

Who we work with

Pharma · Biotech · CROs · R&D Teams · DMPK Teams · Academic & Research Organizations

Supporting organizations that need reliable PK/DMPK analysis, scientific interpretation and translational insight without the overhead of a full-time specialist.

Led by Sahithi Yerrabelli — 10+ years in pharmaceutical DMPK, preclinical PK, translational pharmacokinetics, and scientific reporting.

“We don’t just analyze numbers. We translate pharmacokinetic data into insights that support better development decisions.”

Why SUHA Pharma Consulting

DMPK expertise built on experience, validated tools, and development-focused delivery.

01

10+ years pharma experience

Preclinical through translational PK.

02

WinNonlin & R analysis

Rigorous, validated PK/TK workflows.

03

Development-focused interpretation

Insights for the next decision, not data dumps.

04

Flexible & confidential

Project-based or fractional; MOU before data exchange.

Services

Five capabilities from raw data to development-ready reporting.

01

Preclinical PK & TK

NCA, compartmental analysis, exposure and TK interpretation.

02

Translational PK

Allometric scaling, human exposure and FIH dose estimation.

03

Modeling & Simulation

Scenario testing, dose optimization and profile prediction.

04

Tissue & Excretion

Distribution ratios, recovery and mass-balance calculations.

05

Scientific Reporting

Protocols, reports, tables, figures and presentations.

Our Process

Six structured steps from study intake to a development-ready decision.

  1. Study
  2. Data
  3. Analysis
  4. Interpretation
  5. Translation
  6. Decision
1

Understand

Study objectives, protocol and development question.

2

Protect

Confidentiality and ownership agreed upfront.

3

Analyze

WinNonlin, R and Excel processing.

4

Interpret

PK parameters and findings evaluated.

5

Review

Structured quality check on outputs.

6

Deliver

Clear reports for the next decision.

Experience

Representative capabilities. Client-identifying information is not disclosed.

Preclinical PK Analysis

Concentration-time profiles, PK parameters, scientific interpretation and report writing.

Laboratory scientist preparing pharmaceutical capsules Microscope and test tubes in a research laboratory Medical sample tubes organized on a laboratory cart

Ready to turn your preclinical data into a development decision?